Study Information

Title: Bowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia External
Status: Recruiting participants
Conditions: Head and Neck Cancer; Precancerous Condition
Interventions: Dietary Supplement: Bowman-Birk inhibitor concentrate; Other: placebo
Institutions: Dana-Farber Cancer Institute
Health Topics: Head and Neck Cancer

Contact Information


Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
Boston, MA 02115
Lori J. Wirth, MD
617-632-3090
lori_wirth@dfci.harvard.edu